Vanda Pharmaceuticals
VNDA
#8788
Rank
C$0.32 B
Marketcap
C$5.39
Share price
6.41%
Change (1 day)
-13.17%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2023 (TTM): C$0.37

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C-$6.53. In 2022 the company made an earnings per share (EPS) of C$0.17 a decrease over its 2021 EPS that were of C$0.85.

EPS history for Vanda Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C$0.37116.54%
2022C$0.17-80%
2021C$0.8539.53%
2020C$0.61-80.18%
2019C$3.06334%
2018C$0.70-247.06%
2017C-$0.48-19.05%
2016C-$0.59-55.32%
2015C-$1.33-347.37%
2014C$0.54-156.72%
2013C-$0.94-31.63%
2012C-$1.38172.22%
2011C-$0.51-238.46%
2010C$0.37-119.7%
2009C-$1.86-31.61%
2008C-$2.72-31.32%
2007C-$3.96-99.27%
2006C-$546.3836045.14%
2005C-$1.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.43-244.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$7.40-213.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.07-116.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.52-766.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.40-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.37-197.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
C-$6.19-5.18%๐Ÿ‡บ๐Ÿ‡ธ USA